Roquette and Bonumose Ink Global Deal to Propel Tagatose Growth

Roquette, a prominent global player in plant-based ingredients and pharmaceutical excipients, has entered into a Cooperation Agreement with Bonumose, a pioneer in enzymatic solutions for rare monosaccharide production. This collaboration focuses on advancing tagatose, a natural-origin sweetener known for its proven health benefits.

The partnership between Roquette and Bonumose integrates Roquette's extensive knowledge in starch and starch-based sweetener production with Bonumose's advanced enzymatic technology. This strategic alliance aims to significantly enhance the scalability of tagatose, a natural-origin sweetener with established health benefits. By leveraging synergies between their respective strengths, the agreement underscores Roquette’s commitment to innovative solutions in sugar management, positioning them at the forefront of advancing sustainable and health-conscious ingredients in the global market.

Anne Hirsch, Head of Sugar Management at Roquette, emphasized the strategic significance of partnering with Bonumose to accelerate the expansion of tagatose production. By leveraging Bonumose's cutting-edge enzyme technology, capable of producing high-purity tagatose, Roquette aims to optimize processing efficiency within their extensive starch sweetener production capabilities. This collaboration underscores Roquette's commitment to innovation and sustainability in meeting global demand for alternative sweeteners. Hirsch highlighted that Roquette's expertise complements Bonumose's technology, ensuring scalable and efficient production processes that align with Roquette's vision for sustainable growth in the food and beverage industry. Together, they seek to advance solutions that support healthier and more environmentally friendly sweetening options worldwide.

Ed Rogers, CEO of Bonumose, highlighted the attributes of tagatose, emphasizing its similarity in taste, flavor, and culinary properties to white sugar, along with its health benefits such as reduced calories and an ultra-low glycemic index. He expressed enthusiasm about collaborating with Roquette, citing their strong engineering capabilities and diverse market access. Rogers welcomed Roquette as a valuable addition to their growing network of strategic partners dedicated to promoting the adoption of tagatose in various markets. This partnership underscores Bonumose's commitment to expanding the reach and applications of tagatose as a healthier alternative to traditional sugars.

Bonumose, a late-stage food ingredient and enzyme innovator headquartered in Albemarle County, Virginia, has secured backing from strategic investors and health-focused institutions. They leverage a global network of partners, including industry leader ASR Group. Bonumose's proprietary Bonumose® method continuously produces high-purity, good-for-you ingredients like Tagatose and Allulose from sustainable plant-based sources. Their reach extends beyond sugar alternatives, offering solutions for dietary supplements, agriculture, and animal nutrition. Recognizing the public health impact of their work, the World Economic Forum designated Bonumose a "Technology Pioneer."